AHRQ EPC Series on Improving Translation of Evidence: Use of a Clinical Pathway for C. Difficile Treatment to Facilitate the Translation of Research Findings into Practice.

Jt Comm J Qual Patient Saf

is Chief Quality and Innovation Officer, Vice President for Healthcare Delivery Science, and Director of the Center for Healthcare Delivery Science and Innovation, University of Chicago Medicine.

Published: December 2019

Background: In 2018 the Agency for Healthcare Research and Quality (AHRQ) Evidence-based Practice Center (EPC) Program issued a call for strategies to disseminate AHRQ EPC systematic reviews. In this pilot, findings from the 2016 AHRQ EPC report on Clostridioides difficile infection were translated into a treatment pathway and disseminated via a cloud-based platform and electronic health record (EHR).

Methods: An existing 10-step framework was used for developing and disseminating evidence-based clinical pathways. The development of the EHR intervention was informed by the Five Rights model for clinical decision support and human-computer interaction design heuristics. The researchers used observations and time measurements to describe the impact of the EPC report on pathway development and examined provider adoption using counts of pathway views.

Results: Two main themes emerged: (1) discrepancies between the EPC report and existing guidelines prompted critical discussions about available treatments, and (2) lack of guideline and pathway syntheses in the EPC report necessitated a rapid literature review. Pathway development required 340 hours: 205 for the rapid literature review, 63 for pathway development and EHR intervention design, and 5 for technical implementation of the intervention. Pathways were viewed 1,069 times through the cloud-based platform and 47 times through a hyperlink embedded in key EHR ordering screens.

Conclusion: Pathways can be an approach for disseminating AHRQ EPC report findings within health care systems; however, reports should include guideline and pathway syntheses to meet their full potential. Embedding hyperlinks to pathway content within the EHR may be a viable and low-effort solution for promoting awareness of evidence-based resources.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jcjq.2019.10.002DOI Listing

Publication Analysis

Top Keywords

epc report
20
ahrq epc
16
pathway development
12
pathway
9
cloud-based platform
8
development ehr
8
ehr intervention
8
guideline pathway
8
pathway syntheses
8
rapid literature
8

Similar Publications

Tuberculosis can present myriad manifestations, affecting multiple organ systems. Common central nervous system (CNS) manifestations include vomiting, headache, blurred vision, neck stiffness, altered sensorium, seizures, and focal neurological deficits. Epilepsia partialis continua (EPC) is a rare manifestation of CNS tuberculosis.

View Article and Find Full Text PDF
Article Synopsis
  • - Tuberculosis (TB) is a critical global health issue, and there's an urgent need for effective vaccines; CD8 T-cells, along with CD4 T-cells, are essential for fighting TB.
  • - The study investigates pH-sensitive liposomes as a delivery system for a multi-stage protein vaccine (Ag85b-ESAT6-Rv2034) against TB, aiming to enhance CD8 T-cell responses through improved antigen presentation.
  • - Results show that these liposomes are successfully taken up by immune cells and promote the activation of T-cells, indicating they could be promising candidates for developing effective TB vaccines.
View Article and Find Full Text PDF

Engineered biomimetic nanovesicles-laden multifunctional hydrogel enhances targeted therapy of diabetic wound.

Mater Today Bio

December 2024

Department of Hand Surgery, Union Hospital, Tongji Medical College, Huazhong, University of Science and Technology, Wuhan, 430022, China.

Article Synopsis
  • Angiogenesis is crucial for healing diabetic wounds, and endothelial progenitor cell-derived extracellular vesicles (EPC-EVs) can enhance this process, but their use is limited by low yield and targeting issues.
  • The study developed biomimetic nanovesicles (EPC-NV) from EPCs and modified them with cRGD peptides (mEPC-NV) for better targeting of endothelial cells.
  • A dual hydrogel network was created that combined an acellular dermal matrix with light-cured gelatin to sustainably release mEPC-NV while providing antioxidant and antibacterial properties, making it a promising approach for diabetic wound treatment.
View Article and Find Full Text PDF
Article Synopsis
  • Early palliative care (EPC) is essential for improving the quality of life for advanced cancer patients and their caregivers, but research on psychological evaluations in EPC is limited.
  • A study at the Veneto Institute of Oncology evaluated psychological needs and symptoms in 753 patients, finding that over half reported psychological symptoms, with significant instances of depression and anxiety.
  • The study revealed discrepancies between oncologists' estimates of patients' psychological symptoms and the patients’ self-reports, highlighting the need for better integration of psychological support in the palliative care team.
View Article and Find Full Text PDF

METRNL exerts cytoprotective effects on EPCs via regulation of the E2F1-TXNIP axis in obese limb ischemia.

Cell Signal

February 2025

Department of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, No. 1665, Kongjiang Road, Shanghai 200000, China. Electronic address:

Background: Obesity increases cardiovascular disease risk by impairing angiogenesis, primarily through dysfunction of endothelial progenitor cells (EPCs). METRNL, a recently identified secreted protein, exhibits diverse biological activities. However, its impact on EPC function and its role in obesity-related microvascular dysfunction remain unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!